Swedish Orphan Biovitrum AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.05.16	Swedish Orphan Biovitrum AB (publ): Bo Jesper Hansen sells 8 million shares (GlobeNewswire)
29.04.16	Sobi signs manufacturing agreements with Pfizer (GlobeNewswire)
27.04.16	Sobi publishes its report for the first quarter 2016 (GlobeNewswire)
27.04.16	Sobi publishes 2015 Annual Report (GlobeNewswire)
26.04.16	Orfadin® Oral Suspension approved in the US (GlobeNewswire)
22.04.16	Sobi signs licensing agreement with Affibody for IL-1 (GlobeNewswire)
21.04.16	European patent granted on new formulation of Kineret® (anakinra) (GlobeNewswire)
20.04.16	Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ) (GlobeNewswire)
19.04.16	Invitation - Presentation of Sobi's first quarter results 2016 (GlobeNewswire)
11.04.16	COMP recommends that Alprolix® maintains orphan designation for treatment of haemophilia B (GlobeNewswire)
24.03.16	European Commission approves transfer of marketing authorisation for Elocta® to Sobi (GlobeNewswire)
08.03.16	Sobi announces new date for Annual General Meeting of shareholders (GlobeNewswire)
29.02.16	Sobi updates outlook for 2016 (GlobeNewswire)
26.02.16	Sobi and Biogen receive positive opinion from CHMP for Alprolix® (rFIXFc) for the treatment of haemophilia B (GlobeNewswire)
26.02.16	Bo Jesper Hansen to step down as Chairman of Sobi - Håkan Björklund to be nominated as new Chairman of the Board (GlobeNewswire)
26.02.16	Sobi publishes its report for the fourth quarter and full year 2015 (GlobeNewswire)
23.02.16	Sobi to initiate clinical development programs in acute gout and Still's disease, and receives US patent on new formulation for Kineret® (anakinra) (GlobeNewswire)
17.02.16	Invitation - Presentation of Sobi's fourth quarter and full year results 2015 (GlobeNewswire)
28.01.16	Sobi to present new interim ASPIRE data at EAHAD congress suggesting that patients can reduce bleeding rates with long-term Elocta® treatment (GlobeNewswire)
19.01.16	Sobi's Orfadin® oral suspension granted European patent (GlobeNewswire)
14.01.16	Chief Medical Officer Birgitte Volck to leave Sobi (GlobeNewswire)
11.01.16	Sobi(TM) announces commercial launch of Elocta® in first countries in Europe (GlobeNewswire)
07.01.16	Sobi gains commercial rights for Relistor®, Deflux® and Solesta® from PharmaSwiss (GlobeNewswire)
22.12.15	Sobi receives orphan drug designation for Alprolix® in Switzerland (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.45	2.45 %	K V
Lonza Grp	528.00	1.27 %	K V
Swiss Re	129.20	0.70 %	K V
Logitech Intl	71.42	0.56 %	K V
Part Grp Hldg	1’269.50	0.47 %	K V
Kuehne+Nagel Int	208.10	-0.67 %	K V
Givaudan	3’890.00	-1.09 %	K V
Sonova Hldg	308.50	-1.15 %	K V
Swiss Life Hldg	724.40	-1.25 %	K V
Novartis	92.30	-1.47 %	K V

Nachrichten zu Swedish Orphan Biovitrum AB

Aktien Top/Flop

Meistgelesene Nachrichten